Investigation of Compatibility of Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcriptase-Pcr Kits Containing Different Gene Targets During Coronavirus Disease 2019 Pandemic
| dc.contributor.author | Sarigul, Figen | |
| dc.contributor.author | Doluca, Osman | |
| dc.contributor.author | Akhan, Sila | |
| dc.contributor.author | Sayan, Murat | |
| dc.date.accessioned | 2023-06-16T14:40:33Z | |
| dc.date.available | 2023-06-16T14:40:33Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Aim:In the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reverse transcriptase-PCR (RT-PCR) technique is often used. We evaluated the compatibility of SARS-CoV-2 RT-PCR kits containing different gene targets during the pandemic.Materials & methods:Samples were tested by Bio-Speddy(R)(RdRpgene) and Diagnovital(R)(RdRp + Egenes). The correlation between two assays were determined by Deming regression analysis and chi-square analyses.Results:Diagnovital PCR kit showed amplification in a narrow Ct range and conveniently sharper exponential amplification curves than Bio-Speedy PCR kit. While the correlation between the findings of the two kits was apparent even with single gene target, this correlation increased when a secondary biomarker was added to the correlation calculations.Conclusion:We have observed high correlation between different PCR kits, however, using different PCR kits during the pandemic may provide a more accurate diagnosis of SARS-CoV-2, since despite correlation there are a number of patients showing contradicting diagnosis. | en_US |
| dc.identifier.doi | 10.2217/fvl-2020-0169 | |
| dc.identifier.issn | 1746-0794 | |
| dc.identifier.issn | 1746-0808 | |
| dc.identifier.scopus | 2-s2.0-85091075065 | |
| dc.identifier.uri | https://doi.org/10.2217/fvl-2020-0169 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/2390 | |
| dc.language.iso | en | en_US |
| dc.publisher | Future Medicine Ltd | en_US |
| dc.relation.ispartof | Future Vırology | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | coronavirus | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | RT-PCR | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | Outbreak | en_US |
| dc.title | Investigation of Compatibility of Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcriptase-Pcr Kits Containing Different Gene Targets During Coronavirus Disease 2019 Pandemic | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Sayan, Murat/0000-0002-4374-7193 | |
| gdc.author.id | Sayan, Murat/0000-0002-4374-7193 | |
| gdc.author.id | CETIN AKHAN, SILA/0000-0002-2540-2060 | |
| gdc.author.id | Doluca, Osman/0000-0003-0412-6148 | |
| gdc.author.scopusid | 57210987866 | |
| gdc.author.scopusid | 36056081300 | |
| gdc.author.scopusid | 55989449700 | |
| gdc.author.scopusid | 22036021000 | |
| gdc.author.wosid | Sayan, Murat/H-5848-2013 | |
| gdc.author.wosid | Doluca, Osman/AAQ-5263-2021 | |
| gdc.author.wosid | Sayan, Murat/GZM-2963-2022 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Sarigul, Figen] Hlth Sci Univ, Antalya Educ & Res Hosp, Infect Dis & Clin Microbiol, Antalya, Turkey; [Doluca, Osman] Izmir Univ Econ, Dept Biomed Engn, Izmir, Turkey; [Akhan, Sila] Kocaeli Univ, Infect Dis & Clin Microbiol, Fac Med, Kocaeli, Turkey; [Sayan, Murat] Kocaeli Univ, Fac Med, Clin Lab, PCR Unit, Kocaeli, Turkey; [Sayan, Murat] Near East Univ, DESAM Inst, Nicosia, Northern Cyprus, Turkey | en_US |
| gdc.description.endpage | 524 | en_US |
| gdc.description.issue | 8 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q3 | |
| gdc.description.startpage | 515 | en_US |
| gdc.description.volume | 15 | en_US |
| gdc.description.wosquality | Q4 | |
| gdc.identifier.openalex | W3080283609 | |
| gdc.identifier.pmid | 33005213 | |
| gdc.identifier.wos | WOS:000562430100001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | BRONZE | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 3.0 | |
| gdc.oaire.influence | 2.6955913E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Research Article | |
| gdc.oaire.popularity | 4.369083E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.1538 | |
| gdc.openalex.normalizedpercentile | 0.61 | |
| gdc.opencitations.count | 4 | |
| gdc.plumx.crossrefcites | 4 | |
| gdc.plumx.mendeley | 27 | |
| gdc.plumx.pubmedcites | 2 | |
| gdc.plumx.scopuscites | 4 | |
| gdc.scopus.citedcount | 4 | |
| gdc.virtual.author | Doluca, Osman | |
| gdc.virtual.author | Doluca, Osman | |
| gdc.wos.citedcount | 3 | |
| relation.isAuthorOfPublication | 1c88d6be-5739-4772-a32f-aad0c62dbb5e | |
| relation.isAuthorOfPublication | e0e93d44-9e5e-460d-ada3-7670007ff025 | |
| relation.isAuthorOfPublication.latestForDiscovery | 1c88d6be-5739-4772-a32f-aad0c62dbb5e | |
| relation.isOrgUnitOfPublication | f07c2219-8f05-4f62-93be-5d2ae67a8477 | |
| relation.isOrgUnitOfPublication | 26a7372c-1a5e-42d9-90b6-a3f7d14cad44 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | f07c2219-8f05-4f62-93be-5d2ae67a8477 |
Files
Original bundle
1 - 1 of 1
